China Organic Agriculture, Inc. fka CNOA

[ImOnABoat]

Faruqi & Faruqi, LLP Announces Investigation of China Organic Agriculture, Inc.

Today : Wednesday 30 November 2011

Faruqi & Faruqi, LLP, a leading national securities firm, is investigating potential securities fraud at China Organic Agriculture, Inc. (“China Organic” or the “Company”) (OTC: CNOA.PK).

The investigation focuses on whether the Company and its executives violated federal securities laws by failing to disclose that: (1) despite indicating otherwise, China Organic had received no initial payments for its September 2008 sale of Jilin Songyuan City ErMaPao Green Rice Limited (“ErMaPao”) to Bothven Investments Limited (“Bothven”); (2) the Company only signed an extension payment agreement with Bothven on March 18, 2009 whereby Bothven agreed pay the purchase price of $8,700,000 in 3 installments (30% in July 2009, 30% in September 2009 and 40% in October 2009) – meaning that China Organic would only receive full payment over a year after the transaction date; and (3) China Organic had improperly reported results from ErMaPao as part of the Company’s ongoing operations subsequent to September 2008, despite the fact that the ErMaPao had purportedly been sold at that time.

Request more information now by clicking here: www.faruqilaw.com/CNOA

Take Action

If you purchased China Organic securities between November 12, 2008 and March 24, 2010 and would like to discuss your legal rights, visit www.faruqilaw.com/CNOA. You can also contact us by calling Richard Gonnello or Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to [e-mail] or [e-mail]. Faruqi & Faruqi, LLP also encourages anyone with information regarding China Organic’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential matter.